logo image
search icon
Global Digital Respiratory Devices Market

Digital Respiratory Devices Market Size, Share & Trends Analysis Report By Product Type (Sensors and Apps, Smart Inhalers and Nebulizers), By Indication (Asthma, Chronic Obstructive Pulmonary Disease), By Region, And By Segment Forecasts, 2024-2031

Report ID : 1377 | Published : 2024-02-08 | Pages: 180 | Format: PDF/EXCEL

The Digital Respiratory Devices Market Size is valued at 61.35 Billion in 2023 and is predicted to reach 472.81 Billion by the year 2031 at a 29.34 % CAGR during the forecast period for 2024-2031.

digital respiratory devices

Digital respiratory devices are compromised when connected to smartphone applications or other data-gathering modules for therapeutic or diagnostic purposes. These devices are used to treat and keep track of respiratory disorders like asthma, chronic obstructive pulmonary disease (COPD), and others. As a result of the development of new technologies, such as intelligent inhalers and nebulizers, patients with chronic obstructive pulmonary disease may now enhance their adherence to treatment and quality-of-life measurements. 

The growth will be propelled by the growing need for accurate and timely measurement and delivery of aerosolized medication (COPD). Products that assist in resolving breathing issues include digital respiratory devices. With the rising incidence of respiratory illnesses and the growing global elderly population, the global market for digital respiratory devices is expanding quickly. Various reasons are driving this market, including rising public awareness of respiratory illnesses, improvements in available treatments, and technology breakthroughs.

However, over the anticipated period, issues, including the existence of an unfavourable reimbursement environment and the accessibility of inexpensive goods from local producers, are anticipated to hinder the market's expansion. Major respiratory illnesses like asthma and COPD are still severely underdiagnosed and undertreated despite their high prevalence. The limited awareness of these disorders and the lack of necessary resources to diagnose these diseases is particularly apparent in emerging economies.

Market Segmentation:

The digital respiratory devices market is segmented on the basis of product and indication. Based on product, the market is segmented as sensors and apps, smart inhalers and nebulizers. Based on indication, the market is differentiated into asthma and chronic obstructive pulmonary disease.

Based On Product, The Smart Inhalers And Nebulizers Segment Is Accounted As A Major Contributor In The Digital Respiratory Devices Market.

The smart inhalers and nebulizers sector is predicted to have a major market share in the forecast periods. It is anticipated that the rising air pollution levels, increasing prevalence of asthma and other respiratory diseases, and expanding desire for digital respiratory devices would all contribute to this need. Furthermore, it has been demonstrated that individuals with COPD and asthma use smart inhalers more frequently. Smart inhalers offer more effective assistance and keep track of the medicine inhalation approach compared to traditional inhalers. Novartis International AG received EC approval for Enerzair Breezhaler in July 2020. This is the first digital device (sensor and app) recommended along with asthma medicine in the European Union.

The Chronic Obstructive Pulmonary Disease Segment Witnessed Growth At A Rapid Rate.

The Chronic Obstructive Pulmonary Disease (COPD) category led to a major market share in the forecast period. Two hundred million individuals worldwide suffer from COPD. Additionally, respiratory disorders account for slightly more than 8% of all chronic diseases worldwide. By 2030, COPD will overtake ischemic heart disease and HIV/AIDS to become the fourth-leading causes of mortality, according to a World Health Organization projection made in 2020. The massive rise of COPD is also attributed to people continuing to smoke and higher life expectancies; both developments are especially significant in developing countries.

The North American Digital Respiratory Devices Market Holds A Significant Regional Revenue Share.

Most of the market will be in North America., accounting for a significant share of the total revenue due to the increased prevalence of asthma, COPD, and other chronic respiratory disorders. Approximately, around 25 million Americans suffer from asthma. Additionally, 14.8 million individuals in the United States have COPD, which claims the lives of 150,000 Americans yearly, or one every four minutes. Furthermore, throughout the projected period, the market expansion is anticipated to be fueled by considerable advancements in digital respiratory products and increased acceptance and accuracy. The 2022 reimbursement charges for Current Procedural Terminology (CPT) codes used in Remote Physiologic Monitoring (RPM) and Remote Therapeutic Monitoring (RTM) services (CMS) were published by the U.S. Centers for Medicare & Medicaid Services published. This amendment will increase the demand for and use of digital respiratory devices in the United States during the projected period.

During the forecast period, Asia Pacific is expected to grow at a lucrative rate. Growing COPD and asthma infection rates in China and India are mainly blamed for this expansion. COPD is the number one cause of impairment in China and a significant public health concern. Furthermore, a substantial market driver in this region is the growing need for home healthcare facilities. The considerable growth rate in this region throughout the projection period is also attributed to increasing disposable incomes and changes in lifestyle.

Competitive Landscape

Some Major Key Players In The Digital Respiratory Devices Market:

  • 3M Health Care Limited,
  • Adherium Limited,
  • Amiko Digital Health Limited,
  • AstraZeneca,
  • Boehringer Ingelheim International GmbH,
  • Capsule Technologies,
  • Cognita Labs,
  • Cohero Health,
  • Findair Sp. z. o. o,
  • GlaxoSmithKline plc,
  • Novartis AG,
  • Pneuma Respiratory,
  • Propeller Health,
  • Sensiron AG,
  • Teva Pharmaceuticals Industries Ltd..

 

Digital Respiratory Devices Market Report Scope

Report Attribute

Specifications

Market Size Value In 2023

USD 61.35 Billion

Revenue Forecast In 2031

USD 472.81 Billion

Growth Rate CAGR

CAGR of 29.34 % from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Billion and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

Product Type, Indication

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

3M Health Care Limited, Adherium Limited, Amiko Digital Health Limited, AstraZeneca, Boehringer Ingelheim International GmbH, Capsule Technologies, Cognita Labs, Cohero Health, Findair Sp. z. o. o, GlaxoSmithKline plc, Novartis AG, Pneuma Respiratory, Propeller Health, Sensiron AG, and Teva Pharmaceuticals Industries Ltd.

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

 

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Digital Respiratory Devices Market Snapshot

Chapter 4. Global Digital Respiratory Devices Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis

5.1. by Product Type & Market Share, 2019 & 2031

5.2. Market Size (Value (US$ Mn) & Volume (no. of units) & Forecasts and Trend Analyses, 2019 & 2031 for the following by Product Type:

5.2.1. Sensors and Apps

5.2.2. Smart Inhalers and Nebulizers

Chapter 6. Market Segmentation 2: by Indication Estimates & Trend Analysis

6.1. by Indication & Market Share, 2019 & 2031

6.2. Market Size (Value (US$ Mn) & Volume (no. of units) & Forecasts and Trend Analyses, 2019 & 2031 for the following by Indication:

6.2.1. Asthma

6.2.2. Chronic Obstructive Pulmonary Disease (COPD)

Chapter 7. Digital Respiratory Devices Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Digital Respiratory Devices Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031

7.1.2. North America Digital Respiratory Devices Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2024-2031

7.1.3. North America Digital Respiratory Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

7.2. Europe

7.2.1. Europe Digital Respiratory Devices Market revenue (US$ Million) by Product Type, 2024-2031

7.2.2. Europe Digital Respiratory Devices Market revenue (US$ Million) by Indication, 2024-2031

7.2.3. Europe Digital Respiratory Devices Market revenue (US$ Million) by country, 2024-2031

7.3. Asia Pacific

7.3.1. Asia Pacific Digital Respiratory Devices Market revenue (US$ Million) by Product Type, 2024-2031

7.3.2. Asia Pacific Digital Respiratory Devices Market revenue (US$ Million) by Indication, 2024-2031

7.3.3. Asia Pacific Digital Respiratory Devices Market revenue (US$ Million) by country, 2024-2031

7.4. Latin America

7.4.1. Latin America Digital Respiratory Devices Market revenue (US$ Million) by Product Type, 2024-2031

7.4.2. Latin America Digital Respiratory Devices Market revenue (US$ Million) by Indication, 2024-2031

7.4.3. Latin America Digital Respiratory Devices Market revenue (US$ Million) by country, 2024-2031

7.5. Middle East & Africa

7.5.1. Middle East & Africa Digital Respiratory Devices Market revenue (US$ Million) by Product Type, 2024-2031

7.5.2. Middle East & Africa Digital Respiratory Devices Market revenue (US$ Million) by Indication, 2024-2031

7.5.3. Middle East & Africa Digital Respiratory Devices Market revenue (US$ Million) by country, 2024-2031

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles

8.2.1. 3M Health Care Limited

8.2.2. Adherium Limited

8.2.3. Amiko Digital Health Limited

8.2.4. AstraZeneca

8.2.5. Boehringer Ingelheim International GmbH

8.2.6. Capsule Technologies

8.2.7. Cognita Labs

8.2.8. Cohero Health

8.2.9. Findair Sp. z. o. o

8.2.10. GlaxoSmithKline plc

8.2.11. Novartis AG

8.2.12. Pneuma Respiratory

8.2.13. Propeller Health

8.2.14. Sensiron AG

8.2.15. Teva Pharmaceuticals Industries Ltd.

8.2.16. Other Prominent Players

Segmentation Of Digital Respiratory Devices Market

By Product

  • Sensors and Apps
  • Smart Inhalers and Nebulizers

By Indication

  • Asthma
  • Chronic Obstructive Pulmonary Disease

Digital Respiratory Devices Market

By Region-

  • North America-
  • US
  • Canada
  • Mexico
  • Europe-
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific-
  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific
  • Latin America-
  • Brazil
  • Argentina
  • Rest of Latin America
  • Middle East & Africa-
  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa
  • Others

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Digital Respiratory Devices Market Size?

The Digital Respiratory Devices Market is expected to grow at a 29.34 % CAGR during the forecast period for 2024-2031.

3M Health Care Limited, Adherium Limited, Amiko Digital Health Limited, AstraZeneca, Boehringer Ingelheim International GmbH, Capsule Technologies, Co

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Medical Devices

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach